Result of AGM
09/06/2022 16:01
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220609:nRSI3751Oa&default-theme=true
RNS Number : 3751O Instem plc 09 June 2022
Instem plc
("Instem" or the "Company")
Result of AGM
Instem (AIM: INS.L), a leading provider of IT solutions to the global life
sciences market, announces that at its Annual General Meeting held today,
all resolutions were duly passed. The results of the proxy voting position
received in advance of the meeting are reported below:
No. Resolution For % For Against % Against Withheld
01 Accounts and Reports 13,886,707 89.98% 1,545,989 10.02% 2,094,614
02 Re-elect R A Bandali 17,527,120 100.00% 190 0.00% 0
03 Re-elect D M Sherwin 13,727,503 88.95% 1,705,343 11.05% 2,094,464
04 Re-elect M F McGoun 13,566,252 87.91% 1,866,594 12.09% 2,094,464
05 Re-appoint Auditors 17,527,120 100.00% 190 0.00% 0
06 Auditors Remuneration 17,527,310 100.00% 0 0.00% 0
07 Allot Shares 16,989,283 96.93% 538,027 3.07% 0
08 Allot Equity Securities 16,989,283 96.93% 538,027 3.07% 0
09 Make Market Purchases 17,527,310 100.00% 0 0.00% 0
Notes:
· The full text of each of the resolutions is contained in the
Notice of Annual General Meeting dated 16 May 2022, which is available on the
Company's website at https://www.instem.com (https://www.instem.com) .
· Proxy appointments which gave discretion to the Chairman of the
AGM have been included in the "For" total for the appropriate resolution.
· A "Withheld" vote is not a vote in law and is not counted in the
calculation of the proportion of the votes cast "For" or "Against" a
resolution.
· The issued share capital of the Company as at 09 June 2022 was
22,676,808 ordinary shares of 10p each. No shares are held in treasury.
For further information, please contact:
Instem plc Via Walbrook
Phil Reason, CEO
Nigel Goldsmith, CFO
Singer Capital Markets (Nominated Adviser & Broker) +44 (0) 20 7496 3000
Peter Steel
Alex Bond
Rachel Hayes
Stifel Nicolaus Europe Limited (Joint Broker) +44 (0) 20 7710 7600
Ben Maddison
Alex Price
Walbrook Financial PR +44 (0) 20 7933 8780
Tom Cooper instem@walbrookpr.com
Nick Rome
About Instem
Instem is a leading provider of IT solutions & services to the life
sciences market delivering compelling solutions for Study Management,
Regulatory Submissions, Clinical Trial Acceleration, and Informatics-based
Insight Generation.
Instem solutions are in use by over 700 customers worldwide, including all of
the largest 25 pharmaceutical companies, enabling clients to bring life
enhancing products to market faster. Instem's portfolio of software solutions
increases client productivity by automating study-related processes while
offering the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information.
Instem products and services address aspects of the entire drug development
value chain, from discovery through to market launch. Management estimate that
over 50% of all drugs on the market have been through some part of Instem's
platform during their development.
To learn more about Instem solutions and its mission, please
visit www.instem.com (http://www.instem.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGSSWFLUEESEIM